The emerging evidence regarding the abnormal expression of visfatin in many types of cancers and also significant correlation between high circulating visfatin levels and increased risk of cancer and cancer-related mortality, suggests visfatin as a potential mediator that contributes to the interconnection of obesity and cancer [51]. This evidence concerns the gene NAMPT and obesity disorder.